Protein A Resins Market to surpass $900mn by 2024
Get more details @ http://bit.ly/2pya5qn Major industry companies for Protein A Resins Market include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
Get more details @ http://bit.ly/2pya5qn
Major industry companies for Protein A Resins Market include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Japan <strong>Protein</strong> A Resin <strong>Market</strong> size, <strong>by</strong> matrix type, 2012-<strong>2024</strong> (USD<br />
Million)<br />
Browse key industry insights spread across 127 pages with 123 market data tables &<br />
around 8 figures & charts from this 2017 report <strong>Protein</strong> A <strong>Resins</strong> <strong>Market</strong> in detail<br />
along with the table of contents at:<br />
https://www.frac<strong>to</strong>via.org/news/industry-research-report/protein-a-resins-market<br />
Geographically, U.S. <strong>Protein</strong> A resin industry covered 85% of the <strong>to</strong>tal share in 2015<br />
and is expected <strong>to</strong> continue its regional dominance due <strong>to</strong> the dynamically increasing<br />
healthcare infrastructure related <strong>to</strong> clinical practices. Asia Pacific market is also<br />
anticipated <strong>to</strong> show a striking annual growth rate of 8.5% over the coming seven<br />
years with a major contribution of Japan as it accounted for almost 40% of the <strong>to</strong>tal<br />
share in 2015, Japan protein A resin industry will exceed a revenue worth 78 million<br />
<strong>by</strong> <strong>2024</strong>. Another niche region with a strong growth prospect is Spain, owing <strong>to</strong> the<br />
country’s demand for biosimilar products.<br />
Biopharmaceutical farms and Contract research organizations are the two major end<br />
users of <strong>Protein</strong> A resin industry. Biopharmaceutical industries accounted for a share<br />
of 75% of <strong>Protein</strong> A resin market in 2015, and is expected <strong>to</strong> <strong>surpass</strong> USD 680<br />
million <strong>by</strong> <strong>2024</strong>.CROs accounted for the second highest revenue share in 2015 and<br />
is estimated <strong>to</strong> record USD 130 million with an annual growth rate of 8.1% over the<br />
coming seven years.<br />
Geographic expansion, strategic acquisitions, agreements, and continuous effort <strong>to</strong><br />
enhance the product portfolio are the major strategies adopted <strong>by</strong> the market players<br />
<strong>to</strong> sustain the competitive market.<br />
2 | P a g e
Change language